3 terminated, 1 active not recruiting, 1 completed, 1 unknown. 3 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Active not recruiting 1, Terminated 1, Unknown 1 |
| Early Phase 1 | 1 | Terminated 1 |
Follow Salpingo-oophorectomy: new trials by email Literature Review of Salpingo-oophorectomy trials Research Report on Salpingo-oophorectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Case Report of NMDAR Encephalopathy Magnetic Resonance Imaging (MRI), Salpingo-oophorectomy - Anti-NMDA Receptor Encephalitis, Mature Teratoma | Completed | Mayo Clinic | 1 | 2024-06-20 | 2025-04-08 | |
| Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experience cervical biopsies/conization,, imaging tests (TCTB, TC-PET, MRI), neoadjuvant chemotherapy (cisplatin or carboplatin plus paclitaxel) - Cervical Carcinoma | Terminated | Azienda Policlinico Umberto I | 97 | 2024-04-10 | 2024-12-30 | |
| Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy Denosumab, Salpingo-Oophorectomy - Ovarian Carcinoma | Early Phase 1 | Terminated | National Cancer Institute (NCI) | 2 | 2019-03-14 | 2022-06-14 |
| Risk-Reducing Surgeries for Hereditary Ovarian Cancer salpingo-oophorectomy only by laparoscopy, salpingo-oophorectomy with hysterectomy by laparoscopy, Follow-up - Hereditary Breast and Ovarian Cancer Syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis | Not applicable | Unknown | Lei Li | 600 | 2017-09-01 | 2017-12-26 |
| Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations Laboratory Biomarker Analysis, Oophorectomy, Quality-of-Life Assessment - Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 374 | 2016-05-02 | 2026-07-15 |
| Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer Lymph Node Mapping, Quality-of-Life Assessment, Salpingo-Oophorectomy - Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Not applicable | Terminated | M.D. Anderson Cancer Center | 137 | 2010-04-15 | 2026-01-07 |
Hereditary Breast and Ovarian Cancer Syndrome (2) · Anti-N-Methyl-D-Aspartate Receptor Encephalitis (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Dermoid Cyst (1) · Ovarian Neoplasms (1) · Paraneoplastic Syndromes (1) · Uterine Cervical Neoplasms (1)
M.D. Anderson Cancer Center (2) · Azienda Policlinico Umberto I (1) · Lei Li (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1)
United States (4) · Argentina (1) · Australia (1) · Brazil (1) · China (1) · Colombia (1) · Israel (1) · Italy (1) · Mexico (1) · Peru (1) · Thailand (1)
Kathleen M Schmeler (1) · Lei Li, MD (1) · Powel Brown (1) · Roni N Wilke, MD (1) · Tri A. Dinh, MD (1)
N01CN00034 (1), P30CA016672 (1)